These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 502765)

  • 1. Inhibition of hepatic lipogenesis by 2-tetradecylglycidic acid.
    McCune SA; Nomura T; Harris RA
    Lipids; 1979 Oct; 14(10):880-2. PubMed ID: 502765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Action in vivo and in vitro of 2-tetradecylglycidic acid, 2-tetradecylglycidyl-CoA and 2-tetradecylglycidylcarnitine on hepatic carnitine palmitoyltransferase.
    Brady PS; Brady LJ
    Biochem J; 1986 Sep; 238(3):801-9. PubMed ID: 3800962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of inhibition of fatty acid oxidation on neonatal liver carnitine content.
    Frost SC; Wells MA
    Biochem J; 1982 Jun; 204(3):861-3. PubMed ID: 7126171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relation of oxidation of long-chain fatty acids to gluconeogenesis in the perfused liver of the guinea pig: effect of 2-tetradecylglycidic acid (McN-3802).
    Tutwiler GF; Brentzel HJ
    Eur J Biochem; 1982 Jun; 124(3):465-70. PubMed ID: 7106101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of the oral hypoglycemic agent 2-tetradecylglycidic acid on fatty acid oxidation in suckling rats in vivo and in perfused liver.
    Frost SC; Wells MA
    Arch Biochem Biophys; 1981 Oct; 211(2):547-55. PubMed ID: 7305389
    [No Abstract]   [Full Text] [Related]  

  • 6. Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis.
    Tutwiler GF; Dellevigne P
    J Biol Chem; 1979 Apr; 254(8):2935-41. PubMed ID: 429328
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of the fatty acid oxidation inhibitor 2-tetradecylglycidic acid (TDGA) on glucose and fatty acid oxidation in isolated rat soleus muscle.
    Tuman RW; Joseph JM; Brentzel HJ; Tutwiler GF
    Int J Biochem; 1988; 20(2):155-60. PubMed ID: 3350201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of sodium 2-[5-(4-chlorophenyl)pentyl]-oxirane-2-carboxylate (POCA) on intermediary metabolism in isolated rat-liver cells.
    Vaartjes WJ; De Haas CG; Haagsman HP
    Biochem Pharmacol; 1986 Dec; 35(23):4267-72. PubMed ID: 3790153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Tetradecylglycidic acid.
    Tutwiler GF; Ho W; Mohrbacher RJ
    Methods Enzymol; 1981; 72():533-51. PubMed ID: 7311851
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased secretion of very low density lipoprotein triglyceride following inhibition of long chain fatty acid oxidation in isolated rat liver.
    Ide T; Ontko JA
    J Biol Chem; 1981 Oct; 256(20):10247-55. PubMed ID: 7287708
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of mitochondrial fatty acid oxidation in vivo only slightly suppresses gluconeogenesis but enhances clearance of glucose in mice.
    Derks TG; van Dijk TH; Grefhorst A; Rake JP; Smit GP; Kuipers F; Reijngoud DJ
    Hepatology; 2008 Mar; 47(3):1032-42. PubMed ID: 18302288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methyl 2-tetradecylglycidate, an orally effective hypoglycemic agent that inhibits long chain fatty acid oxidation selectively.
    Tutwiler GF; Mohrbacher R; Ho W
    Diabetes; 1979 Mar; 28(3):242-8. PubMed ID: 446909
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of 2[5(4-chlorphenyl)pentyl]oxirane-2-carboxylate on fatty acid synthesis and fatty acid oxidation in isolated rat hepatocytes.
    Agius L; Pillay D; Alberti KG; Sherratt HS
    Biochem Pharmacol; 1985 Aug; 34(15):2651-4. PubMed ID: 2861821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of mitochondrial carnitine palmitoyl transferase by 2-tetradecylglycidic acid (McN-3802) (preliminary communication).
    Tutwiler GF; Ryzlak MT
    Life Sci; 1980 Feb; 26(5):393-7. PubMed ID: 7366330
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibition of fatty acid synthesis in isolated adipocytes by 5-(tetradecyloxy)-2-furoic acid.
    Halvorson DL; McCune SA
    Lipids; 1984 Nov; 19(11):851-6. PubMed ID: 6549204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of fatty acid oxidation and in normal and hypoxic perfused rat hearts by 2-tetradecylglycidic acid.
    Pearce FJ; Forster J; DeLeeuw G; Williamson JR; Tutwiler GF
    J Mol Cell Cardiol; 1979 Sep; 11(9):893-915. PubMed ID: 226722
    [No Abstract]   [Full Text] [Related]  

  • 17. Reduction of ischemia-induced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts.
    Hekimian G; Feuvray D
    Diabetes; 1986 Aug; 35(8):906-10. PubMed ID: 3732631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of glucose utilization by inhibition of mitochondrial fatty acid uptake in cardiac cells.
    Sharawi S; Mohamoud EM; Nada M; Hendrickson SC; Abdel-Aleem S
    Pharmacol Res; 1995; 32(1-2):43-7. PubMed ID: 8668646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of 2-tetradecylglycidic acid on myocardial function in swine hearts.
    Miller WP; Liedtke AJ; Nellis SH
    Am J Physiol; 1986 Sep; 251(3 Pt 2):H547-53. PubMed ID: 3092680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereospecificity of the inhibition by etomoxir of fatty acid and cholesterol synthesis in isolated rat hepatocytes.
    Agius L; Meredith EJ; Sherratt HS
    Biochem Pharmacol; 1991 Oct; 42(9):1717-20. PubMed ID: 1930298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.